Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Waldencast plc - Class A Ordinary Share
(NQ:
WALD
)
3.080
+0.560 (+22.22%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
320,025
Open
2.510
Bid (Size)
2.910 (100)
Ask (Size)
3.080 (100)
Prev. Close
2.520
Today's Range
2.420 - 3.150
52wk Range
1.480 - 4.180
Shares Outstanding
9,342,874
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
November 16, 2025
Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation
From
Waldencast plc
Via
GlobeNewswire
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
November 14, 2025
From
Waldencast plc
Via
GlobeNewswire
Performance
YTD
-17.6%
-17.6%
1 Month
+69.2%
+69.2%
3 Month
+75.0%
+75.0%
6 Month
+16.7%
+16.7%
1 Year
-7.2%
-7.2%
More News
Read More
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
November 12, 2025
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
October 08, 2025
From
Waldencast plc
Via
GlobeNewswire
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
September 10, 2025
From
Waldencast plc
Via
GlobeNewswire
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
↗
August 19, 2025
Via
Benzinga
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
August 18, 2025
From
Waldencast plc
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Monday?
↗
August 18, 2025
Via
Chartmill
Earnings Scheduled For August 18, 2025
↗
August 18, 2025
Via
Benzinga
Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
↗
August 18, 2025
Via
Benzinga
Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast
July 23, 2025
Via
ACCESS Newswire
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
July 23, 2025
From
Waldencast plc
Via
GlobeNewswire
Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
June 26, 2025
Via
Benzinga
Waldencast Reports Q1 2025 Financial Results
May 13, 2025
From
Waldencast plc.
Via
GlobeNewswire
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
May 06, 2025
From
Waldencast plc.
Via
GlobeNewswire
Waldencast Q1 Preview: Beauty Brand Glow Dims On Soft Margins, Flat Sales
↗
May 06, 2025
Via
Benzinga
Topics
Earnings
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
April 22, 2025
From
Waldencast plc.
Via
GlobeNewswire
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
March 18, 2025
From
Waldencast plc.
Via
GlobeNewswire
Earnings Scheduled For March 18, 2025
↗
March 18, 2025
Via
Benzinga
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
March 11, 2025
From
Waldencast plc.
Via
GlobeNewswire
Waldencast Q4 Earnings Preview: All Eyes On Tariff Impact, Obagi Skincare Brand
↗
March 11, 2025
Via
Benzinga
Topics
World Trade
Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
February 19, 2025
From
Waldencast plc.
Via
GlobeNewswire
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
February 10, 2025
From
Waldencast plc.
Via
GlobeNewswire
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
January 30, 2025
From
Waldencast plc.
Via
GlobeNewswire
Waldencast Announces Participation in the 2025 IMCAS World Congress
January 29, 2025
From
Waldencast plc.
Via
GlobeNewswire
Frequently Asked Questions
Is Waldencast plc - Class A Ordinary Share publicly traded?
Yes, Waldencast plc - Class A Ordinary Share is publicly traded.
What exchange does Waldencast plc - Class A Ordinary Share trade on?
Waldencast plc - Class A Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Waldencast plc - Class A Ordinary Share?
The ticker symbol for Waldencast plc - Class A Ordinary Share is WALD on the Nasdaq Stock Market
What is the current price of Waldencast plc - Class A Ordinary Share?
The current price of Waldencast plc - Class A Ordinary Share is 3.080
When was Waldencast plc - Class A Ordinary Share last traded?
The last trade of Waldencast plc - Class A Ordinary Share was at 11/21/25 04:00 PM ET
What is the market capitalization of Waldencast plc - Class A Ordinary Share?
The market capitalization of Waldencast plc - Class A Ordinary Share is 28.78M
How many shares of Waldencast plc - Class A Ordinary Share are outstanding?
Waldencast plc - Class A Ordinary Share has 29M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.